Browsing: PACB

Recent analyst revisions have brought Pacific Biosciences of California into focus as price targets have shifted into a tighter band around the US$2 to US$2.70 range. These changes reflect updated views from both more optimistic and more cautious analysts who are reassessing the stock as new earnings previews and sector comparisons come through. As you…